Company is bringing the issue at price band of Rs 516-542 per share at p/e multiple of 32x on pre issue FY21 eps basis. RHCL being leading pediatric multi-specialty healthcare chain with strong clinical expertise in managing complex diseases follows Hub-and-spoke model that provides synergies .RHCL has strong track record of growth, operational and financial performance and experienced senior management team with strong institutional shareholder but looking after current...